跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,725 条关于
“[225Ac]Ac-AKY-1189”
全部
2,725
临床试验
1,391
药物
879
机构
275
资讯
180
去年
FDA Clears Phase 1b Trial for Novel Nectin-4 Targeted Radiopharmaceutical AKY-1189 Across Multiple Cancer Types
去年
Novel Mini-Protein AKY-1189 Shows Promise in Targeted Radiation Delivery for Multiple Cancer Types
去年
Aktis Oncology's First-in-Class Nectin-4 Radiopharmaceutical AKY-1189 Shows Promising Tumor Uptake Across Multiple Cancer Types
9天前
FDA Clears IND for Full-Life's Actinium-225 c-MET Radioconjugate [225Ac]Ac-FL-261 in Non-Squamous NSCLC
5个月前
Novel Actinium-225 Radioconjugate Shows Promise Against Treatment-Resistant HER2-Positive Breast Cancer
4年前
Phase 1/2 Trial Investigates 225Ac-J591 and 177Lu-PSMA-I&T Combination in Metastatic Castration-Resistant Prostate Cancer
去年
Ariceum Therapeutics Presents Promising Data on 225Ac-Satoreotide at EANM 2024
4年前
Preliminary Data on 225Ac-J591 Shows Promise in Treating mCRPC
11个月前
Full-Life Technologies Secures $77 Million Series C to Advance Radiopharmaceutical Pipeline and Manufacturing
2年前
FDA Grants Fast Track Designation to 225Ac-FL-020 for Metastatic Castration-Resistant Prostate Cancer
第 1 页,共 18 页
上一页
下一页